Breaking News

Almac, THREAD to Integrate Technologies for Clinical Trials

Integrating technology platforms aims to provide sponsors and CROs with a full range of tools designed to reduce the risk of trial delays.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Almac Clinical Technologies, a member of the Almac Group, and THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), entered a strategic partnership to integrate technologies to enable more efficient clinical trials that generate better outcomes.   By integrating their technology platforms, Almac and THREAD will provide sponsors and contract research organizations (CROs) with a full range of tools designed to reduce the risk of trial delays. Almac’s IXRS solut...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters